Basic loss per share is computed by dividing net loss attributable to holders of Viatris Inc. common stock by the weighted average number of shares outstanding during the period. Diluted loss per share is computed by dividing net loss attributable to holders of Viatris Inc. common stock by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities or instruments, if the impact is dilutive.


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
(In millions, except per share amounts)	2026		2025		2026		2025
Basic loss attributable to Viatris Inc. common shareholders (numerator):
Net loss attributable to Viatris Inc. common shareholders	$	(325.3)	$	(128.2)	$	(267.7)	$	(3,174.8)
Shares (denominator):
Weighted average shares outstanding	1,148.6		1,164.6		1,155.8		1,176.7
Basic loss per share attributable to Viatris Inc. shareholders	$	(0.28)	$	(0.11)	$	(0.23)	$	(2.70)

Diluted loss attributable to Viatris Inc. common shareholders (numerator):
Net loss attributable to Viatris Inc. common shareholders	$	(325.3)	$	(128.2)	$	(267.7)	$	(3,174.8)
Shares (denominator):
Weighted average shares outstanding	1,148.6		1,164.6		1,155.8		1,176.7
Share-based awards	—		—		—		—
Total dilutive shares outstanding	1,148.6		1,164.6		1,155.8		1,176.7
Diluted loss per share attributable to Viatris Inc. shareholders	$	(0.28)	$	(0.11)	$	(0.23)	$	(2.70)

Additional stock options and Restricted Stock Awards were outstanding during the three and nine months ended September 30, 2026 and 2025, but were not included in the computation of diluted loss per share for each respective period because the effect would be anti-dilutive. Excluded shares also include certain PSUs whose performance conditions had not been fully met. Such excluded shares and anti-dilutive awards represented 22.5 million shares and 24.5 million shares for the three and nine months ended September 30, 2026, respectively, and 12.9 million shares and 22.6 million shares for the three and nine months ended September 30, 2025, respectively.

The Company paid a quarterly cash dividend of $0.12 per share on the Company’s issued and outstanding common stock in March 2026, June 2026, and September 2026. On November 2, 2026, the Company’s Board of Directors declared a quarterly cash dividend of $0.12 per share on the Company’s issued and outstanding common stock, which will be payable on December 16, 2026 to shareholders of record as of the close of business on November 23, 2026. The declaration and payment of future dividends to holders of the Company’s common stock will be at the discretion of the Board of Directors, and will depend upon factors, including but not limited to, the Company’s financial condition, earnings, capital requirements of its businesses, legal requirements, regulatory constraints, industry practice, and other factors that the Board of Directors deems relevant. The Company also paid quarterly cash dividends of $0.12 per share on the Company’s issued and outstanding common stock in each of the four quarters of 2025.

On February 28, 2022, the Company announced that its Board of Directors had authorized a share repurchase program for the repurchase of up to $1.0 billion of the Company’s shares of common stock. The Company subsequently announced that on February 26, 2024, its Board of Directors authorized a $1.0 billion increase to the Company’s previously announced $1.0 billion share repurchase program. As a result, the Company’s share repurchase program now authorizes the repurchase of up to $2.0 billion of the Company’s shares of common stock. Such repurchases may be made from time-to-time at the Company’s discretion and effected by any means, including but not limited to, open market repurchases, pursuant to plans in accordance with Rules 10b5-1 or 10b-18 under the Exchange Act, privately negotiated transactions (including accelerated stock repurchase programs) or any combination of such methods as the Company deems appropriate. The program does not have an expiration date. The share repurchase program does not obligate the Company to acquire any particular amount of common stock.